αααααβααΎαEXAS β’ NASDAQ
add
Exact Sciences Corp
102.34$
αααααααααα(0.14%)-0.14
102.20$
ααΆααα·αα 30 ααααΆ, 6:45:31 PM ααααβααα -5 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
102.30$
α
αααααααααααα
102.31$ - 102.56$
α
ααααααα½αααααΆαα
α»αααααα
38.88$ - 102.66$
ααΎαβαα»αβααΈααααΆα
19.53Β αααΈααΆα USD
ααα ααα½αααΌαααααα
2.49Β ααΆα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 850.74Β ααΆα | 20.05% |
α
αααΆαααααα·ααααα·ααΆα | 584.94Β ααΆα | 14.70% |
α
αααΌααα»ααα | -19.59Β ααΆα | 48.76% |
ααααΆααα
αααααα»ααα | -2.30 | 57.41% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.24 | 287.35% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 54.87Β ααΆα | 51.27% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -10.35% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 1.00Β αααΈααΆα | -1.77% |
ααααααααα»α | 5.90Β αααΈααΆα | -12.57% |
ααΆαααα½ααα»αααααΌαααα»α | 3.40Β αααΈααΆα | -3.94% |
ααΌαβααααα»α | 2.50Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 189.47Β ααΆα | β |
ααααααααααΉαααααα
| 7.75 | β |
ααα
ααααααΎαααααα | -0.04% | β |
ααα
ααααααΎααΎααα»α | -0.05% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | -19.59Β ααΆα | 48.76% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 219.92Β ααΆα | 58.54% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -86.45Β ααΆα | -5.80% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -1.53Β ααΆα | -577.88% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 131.94Β ααΆα | 124.96% |
ααα αΌαααΆα
αααααΆααααααα | 194.64Β ααΆα | 80.56% |
α’αααΈ
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
In November 2025, Abbott Laboratories agreed to acquire Exact Sciences in a deal worth roughly $21 billion. Wikipedia
CEO
ααΆααααααΎαα‘αΎα
1 ααααΆ 1995
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
6,950
